Search

Alan L Rotman

Examiner (ID: 15220)

Most Active Art Unit
1201
Art Unit(s)
1802, 1612, 1201, 1203, 2899, 1625
Total Applications
2275
Issued Applications
1794
Pending Applications
68
Abandoned Applications
413

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18351255 [patent_doc_number] => 20230139366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => BRARTEMICIN ANALOGUES [patent_app_type] => utility [patent_app_number] => 18/047708 [patent_app_country] => US [patent_app_date] => 2022-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27175 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047708 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/047708
BRARTEMICIN ANALOGUES Oct 18, 2022 Pending
Array ( [id] => 18162015 [patent_doc_number] => 20230028607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA [patent_app_type] => utility [patent_app_number] => 17/960966 [patent_app_country] => US [patent_app_date] => 2022-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7548 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17960966 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/960966
COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA Oct 5, 2022 Pending
Array ( [id] => 18339918 [patent_doc_number] => 20230131867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => TRITERPENE SAPONINS, METHODS OF SYNTHESIS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/947716 [patent_app_country] => US [patent_app_date] => 2022-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38692 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17947716 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/947716
TRITERPENE SAPONINS, METHODS OF SYNTHESIS AND USES THEREOF Sep 18, 2022 Pending
Array ( [id] => 18518506 [patent_doc_number] => 11708386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root [patent_app_type] => utility [patent_app_number] => 17/946531 [patent_app_country] => US [patent_app_date] => 2022-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4005 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 378 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946531 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/946531
Ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root Sep 15, 2022 Issued
Array ( [id] => 18254107 [patent_doc_number] => 20230081146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => METHODS AND COMPOSITIONS TO PREVENT AND TREAT INFLAMMATION AND ALLERGIC REACTIONS [patent_app_type] => utility [patent_app_number] => 17/931491 [patent_app_country] => US [patent_app_date] => 2022-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931491 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/931491
METHODS AND COMPOSITIONS TO PREVENT AND TREAT INFLAMMATION AND ALLERGIC REACTIONS Sep 11, 2022 Pending
Array ( [id] => 18299334 [patent_doc_number] => 20230109020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => Nucleic Acid and Other Compositions and Methods for the Modulation of Cell Membranes [patent_app_type] => utility [patent_app_number] => 17/941835 [patent_app_country] => US [patent_app_date] => 2022-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21955 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941835 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/941835
Nucleic Acid and Other Compositions and Methods for the Modulation of Cell Membranes Sep 8, 2022 Pending
Array ( [id] => 18034522 [patent_doc_number] => 20220378737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS [patent_app_type] => utility [patent_app_number] => 17/873638 [patent_app_country] => US [patent_app_date] => 2022-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16495 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873638 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/873638
TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS Jul 25, 2022 Pending
Array ( [id] => 18177133 [patent_doc_number] => 20230037862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => SYNTHETIC AGONISTS OF TLR4 RECEPTOR [patent_app_type] => utility [patent_app_number] => 17/813140 [patent_app_country] => US [patent_app_date] => 2022-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7478 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813140 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/813140
SYNTHETIC AGONISTS OF TLR4 RECEPTOR Jul 17, 2022 Pending
Array ( [id] => 18125056 [patent_doc_number] => 20230010671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-12 [patent_title] => PROTON ACTIVATED ATOMIC MEDICINE [patent_app_type] => utility [patent_app_number] => 17/850467 [patent_app_country] => US [patent_app_date] => 2022-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18538 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850467 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/850467
PROTON ACTIVATED ATOMIC MEDICINE Jun 26, 2022 Pending
Array ( [id] => 17851812 [patent_doc_number] => 20220281854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => COMBINATION THERAPY FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/751153 [patent_app_country] => US [patent_app_date] => 2022-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38779 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 291 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751153 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/751153
COMBINATION THERAPY FOR TREATING CANCER May 22, 2022 Pending
Array ( [id] => 17790445 [patent_doc_number] => 20220249536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => ANTIBODY DRUG CONJUGATES [patent_app_type] => utility [patent_app_number] => 17/730924 [patent_app_country] => US [patent_app_date] => 2022-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27723 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730924 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/730924
Antibody drug conjugates Apr 26, 2022 Issued
Array ( [id] => 17807418 [patent_doc_number] => 20220259253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => CD73 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/722513 [patent_app_country] => US [patent_app_date] => 2022-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74599 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -123 [patent_words_short_claim] => 1087 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722513 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/722513
CD73 INHIBITORS Apr 17, 2022 Pending
Array ( [id] => 17944333 [patent_doc_number] => 20220331350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => METHODS FOR TREATMENT AND PROPHYLAXIS OF HIV AND AIDS [patent_app_type] => utility [patent_app_number] => 17/658547 [patent_app_country] => US [patent_app_date] => 2022-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9732 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17658547 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/658547
METHODS FOR TREATMENT AND PROPHYLAXIS OF HIV AND AIDS Apr 7, 2022 Pending
Array ( [id] => 17670944 [patent_doc_number] => 20220184111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY [patent_app_type] => utility [patent_app_number] => 17/682655 [patent_app_country] => US [patent_app_date] => 2022-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22680 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682655 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/682655
METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY Feb 27, 2022 Pending
Array ( [id] => 18109631 [patent_doc_number] => 20230002511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => HIGH-VISCOSITY LITHIUM CARBOXYMETHYL CELLULOSE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/681971 [patent_app_country] => US [patent_app_date] => 2022-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5124 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681971 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/681971
High-viscosity lithium carboxymethyl cellulose and preparation method therefor and application thereof Feb 27, 2022 Issued
Array ( [id] => 17687687 [patent_doc_number] => 20220194979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => METHOD FOR PREPARING DELPHINIUM ACYLATED ANTHOCYANIN [patent_app_type] => utility [patent_app_number] => 17/674860 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4226 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 346 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674860 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/674860
Method for preparing delphinium acylated anthocyanin Feb 17, 2022 Issued
Array ( [id] => 17642270 [patent_doc_number] => 20220170008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME [patent_app_type] => utility [patent_app_number] => 17/674177 [patent_app_country] => US [patent_app_date] => 2022-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13472 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674177 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/674177
POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME Feb 16, 2022 Pending
Array ( [id] => 18091303 [patent_doc_number] => 20220409644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/674032 [patent_app_country] => US [patent_app_date] => 2022-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50421 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674032 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/674032
ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE Feb 16, 2022 Pending
Array ( [id] => 19441229 [patent_doc_number] => 12091470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-17 [patent_title] => Use of poly alpha-1,3-glucan ethers as viscosity modifiers [patent_app_type] => utility [patent_app_number] => 17/667707 [patent_app_country] => US [patent_app_date] => 2022-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36004 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667707 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/667707
Use of poly alpha-1,3-glucan ethers as viscosity modifiers Feb 8, 2022 Issued
Array ( [id] => 17865361 [patent_doc_number] => 20220288096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER [patent_app_type] => utility [patent_app_number] => 17/588507 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10962 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588507 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/588507
COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER Jan 30, 2022 Pending
Menu